英国与欧洲腹膜透析优先政策的表型分析:生存与系统层面启示
该研究基于英国肾脏登记系统2007至2021年96,809例新发透析患者,用无监督聚类识别出三种表型,并在竞争风险框架下比较腹膜透析与血液透析的死亡风险。结果显示血液透析在所有表型中均与更高的透析期死亡累积发生率相关,且关联幅度随年龄增长而减弱。作者认为表型分析可支持个体化选择透析方式并影响系统层面政策。
要点
- 在全部三种数据驱动表型中,血液透析与更高的透析期死亡风险相关。
- 血液透析与死亡风险的关联幅度随年龄增长而减弱,最年轻表型关联最强。
- 表型分析可能有助于更个体化的透析方式选择并支持政策决策。
核心结论
- 在英国当代实践中,血液透析与透析期死亡风险高于腹膜透析相关,且关联幅度随年龄增长而减弱。
研究设计与样本
- 分析英国肾脏登记系统2007至2021年96,809例新发透析成人,采用无监督k-prototypes聚类基于年龄、性别、族裔、原发肾病、血红蛋白、血清白蛋白和移植等待状态识别表型。
- 采用竞争风险方法分析透析期至移植前的死亡,以肾移植为竞争事件,并用jack-knife伪值回归模型计算1年和5年死亡累积发生率。
主要发现
- 新发患者中24%起始腹膜透析,76%起始血液透析。
- 识别出三种可重复表型,主要差异在年龄、血红蛋白和白蛋白水平及移植等待状态。
- 全队列中血液透析与1年死亡累积发生率更高相关(sHR 1.85;95%CI 1.75至1.96),5年亦更高(sHR 1.47;95%CI 1.43至1.51)。
- 分层分析中血液透析在所有表型均与更高死亡相关:1年调整sHR范围1.55(95%CI 1.44至1.68)至2.29(95%CI 1.87至2.80)。
- 5年时关联持续但随年龄增长而减弱:最年轻表型调整sHR 2.42(95%CI 2.23至2.63),中间表型1.55(95%CI 1.48至1.61),最年长表型1.14(95%CI 1.11至1.19)。
临床怎么用
- 在考虑透析方式时,可结合患者表型特征(年龄、血红蛋白、白蛋白、移植等待状态)个体化评估腹膜透析与血液透析的潜在生存差异。
- 表型分析结果可为系统层面推动腹膜透析优先政策提供参考,但需结合当地医疗系统背景。
局限性
- 为注册登记数据的关联性分析,存在残余混杂可能。
- 结果受卫生系统背景影响,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: In a contemporary UK cohort of 96,809 patients, peritoneal dialysis was associated with lower mortality than hemodialysis across all phenotypes. The magnitude of this association varied by phenotype and attenuated with increasing age. Phenotype-based analyses may support more individualized dialysis modality selection and inform system-level policy decisions. BACKGROUND: Whether peritoneal dialysis (PD) is associated with lower mortality than hemodialysis in contemporary practice remains debated, particularly across heterogeneous patient populations and in the presence of competing transplantation. We examined modality-associated mortality differences across data-driven phenotypes of incident dialysis patients in the United Kingdom using a competing-risks framework. METHODS: We analyzed 96,809 adults initiating dialysis in the United Kingdom Renal Registry between 2007 and 2021. Unsupervised k-prototypes clustering was used to derive phenotypes based on age, sex, ethnicity, primary kidney disease, hemoglobin, serum albumin, and transplant-listing status. Mortality during the dialysis phase before transplantation was analyzed using competing-risks methods, treating kidney transplantation as a competing event. Cumulative incidence of death at 1 and 5 years was modeled using jack-knife pseudo-value regression with complementary log-log links, adjusting for demographic and clinical covariates. Dialysis modality (hemodialysis versus PD) was the primary exposure, with stratified analyses performed within each phenotype. A complementary competing-risks analysis examined time to transplantation. RESULTS: Among incident patients, 24% initiated PD and 76% hemodialysis. Three reproducible phenotypes were identified, differing primarily by age, hemoglobin and albumin levels, and transplant-listing status. Across the overall cohort, hemodialysis was associated with a higher cumulative incidence of death before transplantation at both 1 year (subdistribution hazard ratio [sHR], 1.85; 95% confidence interval [CI], 1.75 to 1.96) and 5 years (sHR, 1.47; 95% CI, 1.43 to 1.51). In stratified analyses, hemodialysis was associated with higher mortality across all phenotypes. At 1 year, adjusted sHRs ranged from 1.55 (95% CI, 1.44 to 1.68) to 2.29 (95% CI, 1.87 to 2.80) across clusters. At 5 years, the association persisted but attenuated with increasing age, with adjusted sHRs of 2.42 (95% CI, 2.23 to 2.63) in the youngest phenotype, 1.55 (95% CI, 1.48 to 1.61) in the intermediate phenotype, and 1.14 (95% CI, 1.11 to 1.19) in the oldest phenotype. In complementary analyses, time to transplantation did not differ significantly across phenotypes after adjustment. CONCLUSIONS: In contemporary UK practice, hemodialysis was associated with higher mortality during the dialysis phase compared with PD across distinct patient phenotypes, with time-dependent variation in effect magnitude. These registry-based associations support consideration of phenotype-informed modality selection while acknowledging the potential for residual confounding and the influence of health system context.
引用
- Ali H, Fülöp T, Casula AM, et al. Toward a Peritoneal Dialysis-First Policy in the United Kingdom and Europe: A Phenotype-Based Analysis of Survival and System-Level Implications. Clin J Am Soc Nephrol. 2026. PMID: 42018371. doi:10.2215/CJN.0000001060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。